Young GI angle: Should I go abroad?
2019-01-01 Lobatón, T; Armuzzi, A
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
2013-01-01 Papa, A; Felice, C; Marzo, M; Andrisani, G; Armuzzi, A; Covino, M; Mocci, G; Pugliese D, ; De Vitis, I; Gasbarrini, A; Rapaccini, Gl; Guidi, L
Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location
2021-01-01 Privitera, G; Pugliese, D; Armuzzi, A; Guidi, L
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31
2003-01-01 Armuzzi, A; Ahmad, T; Ling, Kl; de Silva, A; Cullen, S; van Heel, D; Orchard, Tr; Welsh, Ki; Marshall, Se; Jewell, Dp
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease
2019-01-01 Alivernini, S; Pugliese, D; Tolusso, B; Felice, C; Gremese, E; Armuzzi, A
A novel pathogenic role for microvasculature in inflammatory bowel disease
2006-01-01 Danese, S; Papa, A; Scaldaferri, F; Graziani, C; Bonizzi, M; Armuzzi, A; Fedeli, G; Gasbarrini, G; Gasbarrini, A
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
2017-01-01 Pugliese, D; Felice, C; Papa, A; Gasbarrini, A; Rapaccini, Gl; Guidi, L; Armuzzi, A
Helicobacter pylori-related diseases
2001-01-01 Cremonini, F; Gasbarrini, A; Armuzzi, A; Gasbarrini, G
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
2022-01-01 Peyrin-Biroulet, L; Hart, A; Bossuyt, P; Long, M; Allez, M; Juillerat, P; Armuzzi, A; Loftus EV, Jr; Ostad-Saffari, E; Scalori, A; Oh, Ys; Tole, S; Chai, A; Pulley, J; Lacey, S; Sandborn, Wj; HICKORY Study, Group
Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1
2004-01-01 Low, Jh; Williams, Fa; Yang, Xs; Cullen, S; Colley, J; Ling, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Dechairo, Bm; Walton, R; Lench, Nj; Jewell, Dp
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD
2022-01-01 Zagari, Rm; Romano, M; Frazzoni, L; Marasco, G; Dajti, E; Arcidiacono, Pg; Armuzzi, A; Biagi, F; Cannizzaro, R; Cavestro, Gm; Ciacci, C; Monica, F; Peralta, S; Radaelli, F; Bazzoli, F
Epithelial cell turnover and apoptosis
1998-01-01 Anti, M; Armuzzi, A; Gasbarrini, G
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study
2021-01-01 Belleudi, V; Rosa, Ac; Poggi, Fr; Armuzzi, A; Nicastri, E; Goletti, D; Diamanti, Ap; Davoli, M; Agabiti, N; Addis, A
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017-01-01 Magro, F; Gionchetti, P; Eliakim, R; Ardizzone, S; Armuzzi, A; Barreiro-de Acosta, M; Burisch, J; Gecse, Kb; Hart, Al; Hindryckx, P; Langner, C; Limdi, Jk; Pellino, G; Zagórowicz, E; Raine, T; Harbord, M; Rieder, F; European Crohn’s and Colitis Organisation, [ecco].
ECCO IBD Curriculum
2017-01-01 Lindsay, Jo; Irving, Pm; Mantzaris, Gj; Panés, J; Irving, P; López-Sanromán, A; Katsanos, K; Juillerat, P; Maconi, G; Lakatos, P; Annese, V; Armuzzi, A; Bager, P; Bettenworth, D; Chauhan, Uk; Ding, Ns; Feakins, Rm; Fiorino, G; Gisbert, J; Kierkus, J; Levine, A; Mantzaris, G; Panes, J; Peyrin-Biroulet, L; Rieder, F; Russell, R; Siegmund, B; Spinelli, A; Sturm, A; Turner, D; Van Rheenen, P; Vavricka, S; Zagorowicz, E; Högenauer, C; Bossuyt, P; Bogut, A; Knudsen, T; Bjorkesten, Cg; Molander, P; Bourreille, A; Siegmund, B; Koutroubakis, J; Ellul, P; Kierkus, J; Zagorowicz, E; Vieira, Ai; Diculescu, Mm; Drobne, D; Gisbert, J; Strid, H; Celik, Af; Hawthorne, B
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year
2014-01-01 Guidi, Luisa; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
2020-01-01 Panaccione, R; Colombel, Jf; Travis, Spl; Bossuyt, P; Baert, F; Vaňásek, T; Danalıoğlu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Lee, Wj; D'Haens, Gr
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study
2021-01-01 Biasucci, D. G.; Buonsenso, D.; Piano, A.; Bonadia, N.; Vargas, J.; Settanni, D.; Bocci, M. G.; Grieco, D. L.; Carnicelli, A.; Scoppettuolo, G.; Eleuteri, D.; Pascale, G. D.; Pennisi, M. A.; Franceschi, F.; Antonelli, M.; Armuzzi, A.; Gemelli Against COVID-19, Group
Unmet needs of Italian physicians managing patients with inflammatory bowel disease
2019-01-01 Bezzio, C; Imperatore, N; Armuzzi, A; Rizzello, F; Manes, G; Bossa, F; Calabrese, E; Caprioli, F; Daperno, M; Mocciaro, F; Orlando, A; Papi, C; Rispo, A; Saibeni, S; Italian Group For Inflammatory Bowel Disease, (IG-IBD)
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study
2021-01-01 Goessens, L; Colombel, Jf; Outtier, A; Ferrante, M; Sabino, J; Judge, C; Saeidi, R; Rabbitt, L; Armuzzi, A; Domenech, E; Michalopoulos, G; Cremer, A; García-Alonso, Fj; Molnar, T; Karmiris, K; Gecse, K; Van Oostrom, J; Löwenberg, M; Farkas, K; Atreya, R; Ribaldone, Dg; Selinger, C; Hoentjen, F; Bihin, B; Sebastian, S; European COMBIO study, Group; Rahier, Jf
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Young GI angle: Should I go abroad? | 1-gen-2019 | Lobatón, T; Armuzzi, A | |
| Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents | 1-gen-2013 | Papa, A; Felice, C; Marzo, M; Andrisani, G; Armuzzi, A; Covino, M; Mocci, G; Pugliese D, ; De Vitis, I; Gasbarrini, A; Rapaccini, Gl; Guidi, L | |
| Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location | 1-gen-2021 | Privitera, G; Pugliese, D; Armuzzi, A; Guidi, L | |
| Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31 | 1-gen-2003 | Armuzzi, A; Ahmad, T; Ling, Kl; de Silva, A; Cullen, S; van Heel, D; Orchard, Tr; Welsh, Ki; Marshall, Se; Jewell, Dp | |
| Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease | 1-gen-2019 | Alivernini, S; Pugliese, D; Tolusso, B; Felice, C; Gremese, E; Armuzzi, A | |
| A novel pathogenic role for microvasculature in inflammatory bowel disease | 1-gen-2006 | Danese, S; Papa, A; Scaldaferri, F; Graziani, C; Bonizzi, M; Armuzzi, A; Fedeli, G; Gasbarrini, G; Gasbarrini, A | |
| Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future | 1-gen-2017 | Pugliese, D; Felice, C; Papa, A; Gasbarrini, A; Rapaccini, Gl; Guidi, L; Armuzzi, A | |
| Helicobacter pylori-related diseases | 1-gen-2001 | Cremonini, F; Gasbarrini, A; Armuzzi, A; Gasbarrini, G | |
| Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial | 1-gen-2022 | Peyrin-Biroulet, L; Hart, A; Bossuyt, P; Long, M; Allez, M; Juillerat, P; Armuzzi, A; Loftus EV, Jr; Ostad-Saffari, E; Scalori, A; Oh, Ys; Tole, S; Chai, A; Pulley, J; Lacey, S; Sandborn, Wj; HICKORY Study, Group | |
| Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1 | 1-gen-2004 | Low, Jh; Williams, Fa; Yang, Xs; Cullen, S; Colley, J; Ling, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Dechairo, Bm; Walton, R; Lench, Nj; Jewell, Dp | |
| Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD | 1-gen-2022 | Zagari, Rm; Romano, M; Frazzoni, L; Marasco, G; Dajti, E; Arcidiacono, Pg; Armuzzi, A; Biagi, F; Cannizzaro, R; Cavestro, Gm; Ciacci, C; Monica, F; Peralta, S; Radaelli, F; Bazzoli, F | |
| Epithelial cell turnover and apoptosis | 1-gen-1998 | Anti, M; Armuzzi, A; Gasbarrini, G | |
| Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study | 1-gen-2021 | Belleudi, V; Rosa, Ac; Poggi, Fr; Armuzzi, A; Nicastri, E; Goletti, D; Diamanti, Ap; Davoli, M; Agabiti, N; Addis, A | |
| Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders | 1-gen-2017 | Magro, F; Gionchetti, P; Eliakim, R; Ardizzone, S; Armuzzi, A; Barreiro-de Acosta, M; Burisch, J; Gecse, Kb; Hart, Al; Hindryckx, P; Langner, C; Limdi, Jk; Pellino, G; Zagórowicz, E; Raine, T; Harbord, M; Rieder, F; European Crohn’s and Colitis Organisation, [ecco]. | |
| ECCO IBD Curriculum | 1-gen-2017 | Lindsay, Jo; Irving, Pm; Mantzaris, Gj; Panés, J; Irving, P; López-Sanromán, A; Katsanos, K; Juillerat, P; Maconi, G; Lakatos, P; Annese, V; Armuzzi, A; Bager, P; Bettenworth, D; Chauhan, Uk; Ding, Ns; Feakins, Rm; Fiorino, G; Gisbert, J; Kierkus, J; Levine, A; Mantzaris, G; Panes, J; Peyrin-Biroulet, L; Rieder, F; Russell, R; Siegmund, B; Spinelli, A; Sturm, A; Turner, D; Van Rheenen, P; Vavricka, S; Zagorowicz, E; Högenauer, C; Bossuyt, P; Bogut, A; Knudsen, T; Bjorkesten, Cg; Molander, P; Bourreille, A; Siegmund, B; Koutroubakis, J; Ellul, P; Kierkus, J; Zagorowicz, E; Vieira, Ai; Diculescu, Mm; Drobne, D; Gisbert, J; Strid, H; Celik, Af; Hawthorne, B | |
| Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year | 1-gen-2014 | Guidi, Luisa; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro | |
| Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial | 1-gen-2020 | Panaccione, R; Colombel, Jf; Travis, Spl; Bossuyt, P; Baert, F; Vaňásek, T; Danalıoğlu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Lee, Wj; D'Haens, Gr | |
| Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study | 1-gen-2021 | Biasucci, D. G.; Buonsenso, D.; Piano, A.; Bonadia, N.; Vargas, J.; Settanni, D.; Bocci, M. G.; Grieco, D. L.; Carnicelli, A.; Scoppettuolo, G.; Eleuteri, D.; Pascale, G. D.; Pennisi, M. A.; Franceschi, F.; Antonelli, M.; Armuzzi, A.; Gemelli Against COVID-19, Group | |
| Unmet needs of Italian physicians managing patients with inflammatory bowel disease | 1-gen-2019 | Bezzio, C; Imperatore, N; Armuzzi, A; Rizzello, F; Manes, G; Bossa, F; Calabrese, E; Caprioli, F; Daperno, M; Mocciaro, F; Orlando, A; Papi, C; Rispo, A; Saibeni, S; Italian Group For Inflammatory Bowel Disease, (IG-IBD) | |
| Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study | 1-gen-2021 | Goessens, L; Colombel, Jf; Outtier, A; Ferrante, M; Sabino, J; Judge, C; Saeidi, R; Rabbitt, L; Armuzzi, A; Domenech, E; Michalopoulos, G; Cremer, A; García-Alonso, Fj; Molnar, T; Karmiris, K; Gecse, K; Van Oostrom, J; Löwenberg, M; Farkas, K; Atreya, R; Ribaldone, Dg; Selinger, C; Hoentjen, F; Bihin, B; Sebastian, S; European COMBIO study, Group; Rahier, Jf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891